Litcius/Paper detail

Metastatic squamous cell carcinoma arising from mature teratoma of the ovary: Description of multi-modality treatment including incorporation of adjuvant immunotherapy and maintenance PARP inhibitor therapy

Esther Peluso, Wesleigh Edwards, Jo Marie Tran Janco

2024Gynecologic Oncology Reports10 citationsDOIOpen Access PDF

Abstract

•Squamous cell carcinoma arising from mature teratoma of the ovary is a rare occurrence without clear agreement regarding optimal treatment.•Multimodality treatment should be considered, particularly for metastatic disease.•Maintenance therapy may be considered.

Topics & Concepts

MedicineImmunotherapyOvaryAdjuvantTeratomaAdjuvant therapyCancer researchBasal cellOncologyPathologyInternal medicineCancerOvarian cancer diagnosis and treatmentChromatin Remodeling and CancerTesticular diseases and treatments
Metastatic squamous cell carcinoma arising from mature teratoma of the ovary: Description of multi-modality treatment including incorporation of adjuvant immunotherapy and maintenance PARP inhibitor therapy | Litcius